[{"address1": "180 North LaSalle Street", "address2": "Suite 1600", "city": "Chicago", "state": "IL", "zip": "60601", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase I clinical trial for the treatment of hypothyroidism; and non-aqueous XeriSol and XeriJect technologies for various therapies. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 918153, "exercisedValue": 0, "unexercisedValue": 148377}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 681142, "exercisedValue": 0, "unexercisedValue": 15586}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 695443, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1206766, "exercisedValue": 0, "unexercisedValue": 590310}, {"maxAge": 1, "name": "Dr. Kenneth E. Johnson Pharm. D., Pharm.D.", "age": 61, "title": "Senior VP of Global Development & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 596967, "exercisedValue": 0, "unexercisedValue": 31173}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.13, "open": 4.1, "dayLow": 4.05, "dayHigh": 4.4, "regularMarketPreviousClose": 4.13, "regularMarketOpen": 4.1, "regularMarketDayLow": 4.05, "regularMarketDayHigh": 4.4, "payoutRatio": 0.0, "beta": 1.208, "forwardPE": -19.272726, "volume": 5382358, "regularMarketVolume": 5382358, "averageVolume": 1713340, "averageVolume10days": 2439670, "averageDailyVolume10Day": 2439670, "bid": 4.2, "ask": 4.29, "bidSize": 1, "askSize": 3, "marketCap": 652705536, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 4.5, "priceToSalesTrailing12Months": 3.2141898, "fiftyDayAverage": 3.5592, "twoHundredDayAverage": 2.93475, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 852532160, "profitMargins": -0.27003, "floatShares": 146386293, "sharesOutstanding": 153940000, "sharesShort": 10265230, "sharesShortPriorMonth": 10361048, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0689, "heldPercentInsiders": 0.03805, "heldPercentInstitutions": 0.42886, "shortRatio": 7.27, "shortPercentOfFloat": 0.0706, "impliedSharesOutstanding": 149080992, "bookValue": -0.198, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54836000, "trailingEps": -0.37, "forwardEps": -0.22, "enterpriseToRevenue": 4.198, "enterpriseToEbitda": -55.087, "52WeekChange": 0.83555555, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 4.24, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.08333, "targetMedianPrice": 6.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 71621000, "totalCashPerShare": 0.465, "ebitda": -15476000, "totalDebt": 271447008, "quickRatio": 1.115, "currentRatio": 1.669, "totalRevenue": 203070000, "revenuePerShare": 1.384, "returnOnAssets": -0.05333, "grossProfits": 166238000, "freeCashflow": -27807376, "operatingCashflow": -36981000, "revenueGrowth": 0.354, "grossMargins": 0.81861997, "ebitdaMargins": -0.07621, "operatingMargins": 0.12944001, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "exchange": "NMS", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1713340, "fiftyTwoWeekLowChange": 2.5499997, "fiftyTwoWeekLowChangePercent": 1.5088755, "fiftyTwoWeekRange": "1.69 - 4.5", "fiftyTwoWeekHighChange": -0.26000023, "fiftyTwoWeekHighChangePercent": -0.05777783, "fiftyTwoWeekChangePercent": 83.55556, "earningsTimestamp": 1741262400, "earningsTimestampStart": 1746702000, "earningsTimestampEnd": 1747047600, "earningsCallTimestampStart": 1741267800, "earningsCallTimestampEnd": 1741267800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.22, "fiftyDayAverageChange": 0.6807997, "fiftyDayAverageChangePercent": 0.19127886, "twoHundredDayAverageChange": 1.3052497, "twoHundredDayAverageChangePercent": 0.4447567, "priceToBook": -21.41414, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-03-07", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": -1.61084, "postMarketPrice": 4.1717, "postMarketChange": -0.0682998, "regularMarketChange": 0.10999966, "regularMarketDayRange": "4.05 - 4.4", "corporateActions": [], "postMarketTime": 1741395326, "regularMarketTime": 1741381201, "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.6634297, "regularMarketPrice": 4.24, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]